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Biologic unicompartmental knee replacement 
J. Farr, United States of America 
This essay’s purpose is to explore and stimulate discussion 
regarding the concept of a biologic knee replacement. While the 
topic is certainly not new, the time may be approaching when 
implementation can expand from the current incremental evolution 
of standard cartilage repair/ restoration techniques. That is, 
UIF ¾STU TVSHJDBM DBSUJMBHF SFQBJS SFTUPSBUJPO QSPDFEVSFT XFSF
primarily used for isolated monopolar defects of articular cartilage 
PS JTPMBUFENFOJTDBM EF¾DJFODZ &BSMZ TFSJFT TVHHFTUFE UIBUNPSF
extensive chondrosis was associated with poor results (Gross 
stopped performing bipolar osteochondral allografts because of the 
failure rate and for the same reason Noyes recommended meniscal 
transplants should not be performed in compartments with greater 
than grade 2 chondrosis). Gradually, however, with the early success 
of isolated techniques, surgeons continued to attempt to expand the 
indications for cartilage repair/ restoration to more extensive knee 
cartilage pathology and again met with varying degrees of success. 
5IFDVSSFOUTUBUFPGUIFBSUJTBQSPDFTTPGBEKVTUJOHBOE¾OFUVOJOH
the algorithm of treatment for these complex knee problems in 
an effort to achieve reproducible results for patients with bipolar 
unicompartmental chondrosis and eventually, even more extensive 
pathologies. 
Biologic unicompartmental knee replacement may be analyzed in 
many ways. Historically, both biologic and standard endoprosthetic 
unicompartmental knee replacements (UKA) are resurfacing 
procedures and can be applied to both the tibiofemoral and 
patellofemoral compartment. To aid in expanding discussion for 
algorithm development, the knee is typically divided into three uni-
compartments: medial and lateral tibio-femoral and patellofemoral. 
As the presentations and treatment options are somewhat different, 
the current discussion will consider both tibio-femoral compartments 
together and the patellofemoral compartment separately. As will 
become evident, performing a biologic unicompartmental knee 
replacement involves much more than resurfacing the bone with 
articular cartilage. 
The patellofemoral (PF) compartment has several unique 
considerations that are much more expansive than cartilage 
pathology alone. Obviously, the patellofemoral pain patient is very 
complex and assigning a component of their pain to the chondral 
pathology is one largely of exclusion. That is, the articular cartilage 
is aneural and the pain is, therefore, originating in the bone or soft 
tissues surrounding the compartment. Before proceeding to bipolar 
PF articular cartilage resurfacing, it is necessary to understand why 
the lesion occurred and to appreciate the biomechanical environment 
of the compartment. [For a background on the PF compartment 
please refer to a chapter on “Patellofemoral Articular Cartilage 
Treatment” in a 2005 AAOS monograph on “Common Patellofemoral 
Problems” edited by Fulkerson and a 2006 review by Gomoll et. al. 
on “Patellofemoral Cartilage Treatments”]. One useful tool in 
evaluating PF compartment chondrosis is to divide PF patients into 
CJPNFDIBOJDBMMZ TJNJMBS HSPVQT 5IJT DMBTTJ¾DBUJPO BMMPXT GPS UIF
development of a rationale approach to treatment. For purposes of 
discussion, dividing the PF patients into one of three PF groups (with 
overlap) is useful: 1) the patella is located excessively laterally with 
reference to the trochlea and/or the patella is excessively tilted, 2) 
the PF anatomy is dysplastic with or without excessive lateral patellar 
position or recurrent lateral patellar instability and 3) those with a 
congruent PF joint (PF alignment parameters and morphology within 
the mean of asymptomatic patients). [Please note that the words 
malalignment, subluxation and normal were purposely avoided in 
light of the controversy surrounding them]. During cartilage 
resurfacing, the underlying goal is to optimize the biomechanical 
environment for the cartilage implant. Cartilage surgeons collectively 
learned this important concept with the groundbreaking initial 
autologous cultured chondrocyte series reported by Brittberg and 
Peterson. The tibiofemoral compartment implants performed well, 
but 5 of 7 PF implant patients had poor results. As a subset of these 
patients with poor results had persistent excessively laterally 
positioned patellae, patients thereafter had concomitant 
“realignment patellofemoral surgery”. Using this approach, a 
subsequent series of patients results were published from the same 
group and with concomitant treatment of any “malalignment” (tibial 
tuberosity medialization or anteromedialization were added to the 
cartilage procedure), they reported markedly improved PF results. 
From that point forward, tibial tubercle surgery became a 
recommended part of the PF cartilage restoration algorithm. During 
UIFTBNFUJNFGSBNFUIFQBUFMMPGFNPSBMTQFDJ¾DMJUFSBUVSFEFUBJMFE
the measurement of the tibial tuberosity to trochlear groove distance. 
This added an objective element to the decision on whether or not to 
move the tibial tuberosity medially (mean distance of asymptomatic 
patient is 13 mm and suggested outlier distances are greater than 20 
mm). Andrish’s lab demonstrated the deleterious effect of over-
medialization on both the medial PF compartment and the medial 
UJCJPGFNPSBM 	5'
DPNQBSUNFOU5IPTF¾OEJOHTXFSFDPSSPCPSBUFE
as we collaborated with Cole’s lab were Tekscan pressure sensors 
showed an increased in medial forces and decreased lateral PF 
forces with anteromedialization. In 2005, Minas published his PF 
autologous cultured chondrocyte implantation (ACI) results showing 
better results than expected by AMZ alone referencing the Pidoriano 
review of Fulkerson AMZ results in which cartilage lesions were not 
resurfaced. Minas did not perform tibial tuberosity surgery on all his 
patients while Henderson in 2006 reported his PF ACI series in which 
one group had AMZ and the other did not. He found better outcomes 
in the AMZ group and suspected “subtle malalignment” might not 
have been recognized in the non-AMZ group. In both of these studies 
the decision to perform AMZ was largely a clinical one as they 
predated the general use of tibial tuberosity trochlear groove 
NFBTVSFNFOUT5IFXBUFSTXFSFGVSUIFSDMPVEFECZ¾OJUFFMFNFOU
analysis modelling by Ateshian and Cohen who found that AMZ 
candidates would be expected to have a quite variable and 
individualistic response to elevation and medialization and that the 
overall decrease in forces with AMZ was on the order of 20% rather 
than the historically quoted 50% reduction. There is also debate in 
regards to the treatment of PF dysplasia and patellofemoral lateral 
recurrent instability. As this group not uncommonly suffers medial 
patellar facet and lateral marginal femoral condyle chondral damage, 
they can present both with instability and chondral defect related 
pain. One area of agreement is the importance of the medial 
patellofemoral ligament (MPFL) in preventing lateral instability. The 
MPFL can be repaired or reconstructed to prevent further instability 
episodes. The extent to which the PF joint soft tissue envelope is 
further balanced with a titrated lateral release or lengthening is 
under debate as is the need for concomitant tuberosity surgery 
	'JUIJBOGFMUUIFSFXBTOPBEEJUJPOBMCFOF¾UPGUVCFSPTJUZNFEJBMJ[BUJPO
after his series compared these two treatment options). Appreciating 
this ongoing debate, there is general consensus that PF stability 
should be established using an anatomy based technique without 
over-constraint. The third group of PF chondrosis patients are those 
with a congruent PF joint without dysplasia. It would appear that 
within this group there are two subgroups: 1) one group that has a 
high genetic predisposition to osteoarthritis and the PF compartment 
IBQQFOTUPCFUIF¾STUDPNQBSUNFOUUPQSFTFOU
XIJMFUIFTFDPOE
subgroup is a result of exceeding high and repetitive loading such as 
JO KVNQJOH PS MPBEFE ¿FYFE LOFF TQPSUT 	FH IJHI MFWFM TLJJOH
basketball, etc). It would appear that the long-term treatment goal in 
UIF ¾STU TVCHSPVQ XPVME OPU CF NFU VOUJM UIF HFOFUJD LFZ UP
osteoarthritis is discovered. For the second subgroup, optimizing 
the PF compartment environment could be to alter the cartilage 
implant loading by altering activities, not necessarily by elevating 
the tibial tuberosity. Now that the underlying coexisting conditions 
are acknowledged, the biologic resurfacing can be addressed. To be 
considered a biologic PF arthroplasty, only bipolar problems will be 
discussed. The standard articular cartilage treatment options of 
marrow stimulation, autograft plugs, allograft and cell therapy were 
reviewed: only series with allograft and cell therapy have bipolar 
listed. Using either approach, it would seem prudent to review the 
success of endoprosthetic PFA for pearls on expectations. In PFA 
series, those with prior trauma or dysplasia have the best outcomes 
BOE UIPTF XJUI DPOHSVFOU 1' KPJOUT XJUI BSUISJUJT BT UIF ¾STU
presentation of tricompartmental osteoarthritis often fail by TF 
osteoarthritis progression. In the limited published biologic PFA 
series, Bugbee reports a bipolar PF osteochondral allograft (OCA) 
shell success of approximately 50%. He noted that many of these 
were antibody positive. Antibody positive patients, in general had 
more transplanted tissue, e.g., bipolar transplants. In all his 
allografts, there was a trend for poorer results in antibody positive 
patients. Bugbee did not alter the position of the tibial tuberosity. In 
our series (submitted for publication), we also noted a 50% failure 
rate and comparing those patients with and without AMZ, there was 
a trend toward better outcomes in the AMZ group, but the numbers 
were too small for statistical analysis and the TT-TG distance was not 
measured. The failures occurred both from failure of the bone to 
incorporate (AVN-like failure) and deterioration of the articular 
cartilage, noting the later is of increased concern now with stored 
allograft tissue as opposed to Bugbee’s early cases of truly fresh 
transplantations. Minas reported his PF ACI series, which included 
24 bipolar cases and an overall 71% good and excellent outcome. Of 
these, 19 (79%) had AMZ. Henderson reported a series with two 
subgroups: those with and without AMZ. Overall the groups have 
54.5% and 86% good and excellent results for the ACI alone or with 
AMZ, respectively. In Peterson’s series, there were overall 84% good 
and excellent results while in the PF group had 65% good and 
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FYDFMMFOUSFTVMUT	*UJTEJG¾DVMUUPEFMJOFBUFUIFOVNCFSPGCJQPMBS1'
knees). In a series accepted for publication, we have reported on 39 
PF ACI patients all over 2 years of follow up with a subset of 6 bipolar 
patients (bipolar lesions in 7 knees). These patients had 6 knees 
(86%) with good and excellent results, with 6 knees having 
concomitant AMZ and 1 knee having a prior AMZ. The pre-op 
categories were: 5 excessive lateral patellar position, 0 with history 
of lateral patellar instability and 2 with congruent stable PF 
compartment, noting the numbers were too small for meaningful 
DPNNFOUSFHBSEJOHJO¿VFODFPOPVUDPNF"MUIPVHIXJUIWFSZTNBMM
numbers, it appears that a biologic PFA does have a role in the 
treatment of patients especially in the decades of life when 
endoprosthetic PFA is suboptimal. Furthermore, the biologic PFA 
does not interfere with conversion to a standard PFA or total joint 
arthroplasty. While the tibiofemoral (TF) compartments have unique 
considerations from the patellofemoral compartment, a universal 
concept does apply: optimizing the environment for the cartilage 
JNQMBOU4QFDJ¾DUPUIF5'DPNQBSUNFOUTBSFUIFSPMFPGUIFNFOJTDVT
TUBCJMJUZBGGPSEFECZTQFDJ¾DMJHBNFOUTBOEDPSPOBMQMBOFBMJHONFOU
considerations. Many of the patients that would be considered for 
endoprosthetic UKA have both articular and meniscal cartilage 
pathology. The meniscus has many functions, but the primary 
purpose is to decrease the stress to the articular cartilage. The 
concept of “margin of safety” applies: that is, the articular cartilage 
in patients with optimal cartilage (from genetic standpoint) is able to 
function for the lifetime of an individual. However, even this “Grade 
A” cartilage will deteriorate when exposed to loads that exceed the 
margin of safety. In extension the medial meniscus transfers 
approximately 50% of the medial compartment load and the lateral 
meniscus 70%. The importance of the lateral meniscus is emphasized 
by the fact that in gait analysis with neutral alignment, the medial 
compartment bears approximately 60% of the TF forces, yet the 
lateral compartment cartilage typically deteriorates earlier with loss 
of meniscal function (studies are with total meniscectomies). This 
implies that subtotal (partial) meniscectomy may allow the 
compartment to stay within the margin of safety. However, all partial 
meniscectomies are not the same. We collaborated with Cole to 
show that interruption of circumferential bundles anywhere in the 
arc negates the entire hoop stress transfer, e.g., removal of a “small” 
¿BQUFBSGSPNUIFQPTUFSJPSIPSOUPUIFNFOJTDPDBQTVMBSKVODUJPOJT
CJPNFDIBOJDBMMZ B UPUBM NFOJTDFDUPNZ 'SPN UIJT MPHJD ¿PX JU JT
understandable that it may be useful for articular cartilage implants 
UP CFOF¾U GSPN UIF SFQMBDFNFOU PG NFOJTDBM GVODUJPO 	UIPVHI
excellent results have been reported with ACI without meniscal 
replacement, noting that in those cases, compartment loading was 
decreased by unloading osteotomy). If it is elected to perform a 
meniscal replacement, as there is a symbiotic relationship between 
the meniscus and articular cartilage, typically the meniscal 
substitution is performed concomitantly with articular cartilage 
restoration. Tibiofemoral realignment has a long history, but in years 
prior to cartilage restoration, realignment procedures were used 
primarily as alternatives to unicompartmental or total joint 
replacement. In that setting, it was established that for medial knee 
arthrosis with varus alignment, over-correction was necessary. For 
valgus knees with lateral compartment pathology, the correction 
was to neutral alignment. This made biomechanical sense in light of 
the asymmetrical knee compartment loading during gait. However, 
when used in conjunction with cartilage restoration, the goal is 
normalization of forces with less overcorrection, especially in the 
young patient where over-correction could cause wear in the non-
involved compartment over time. This is analogous to the 
endoprosthetic UKA literature that repeatedly demonstrates the 
deleterious contralateral compartment effect of over correcting the 
LOFF 	²TUVG¾OH UIF EJTFBTFE DPNQBSUNFOU³
 5IF UFDIOJRVF PG
correcting TF malalignment for cartilage restoration is otherwise the 
same as classically recognized (proximal tibial osteotomy for varus 
knees and distal femoral varus osteotomy for valgus knees except in 
cases were performing the osteotomy at the tibia would not cause 
joint line obliquity). The realignment procedures may be performed 
in a staged or concomitant manner with cartilage restoration. 
Ligamentous patholaxity can be deleterious to articular cartilage in a 
variety of mechanisms: examples include PCL laxity that allows 
posterior subluxation and resultant increases loading primarily in 
the medial compartment with loss of meniscal loading, ACL laxity 
that increases shear forces and lateral collateral laxity that allows 
double varus knee loading. The repair or reconstructions for these 
patholaxities are addressed in a staged or concomitant manner, 
OPUJOH UIBU UIF LOFF BOE MPXFS FYUSFNJUZNVTDVMBUVSF CFOF¾U CZ
undergoing as few surgical interventions as possible. While the TF 
articular cartilage may be restored in any of the multiple available 
techniques, use in a bipolar setting would be testing the limits of any 
approach. The positive potential of bipolar articular cartilage 
restoration, at present, involves ACI and allograft. Bipolar TF 
allografts and ACI are both challenging and have lower success rates 
than unipolar treatments, but use the same basic techniques. The 
environment for the implant is optimized in regards to alignment, 
stability and meniscal function as discussed above. Using these 
principles, there are limited series in the literature that report bipolar 
TF articular cartilage restoration. Gross noted limited success with 
bipolar allograft and abandoned the technique, while Bugbee has 
continued to use allograft in selected bipolar salvage patients with 
some success. We have noted a similar modest positive result. Two 
series have focused on concomitant MAT and ACI, with our series 
including bipolar salvages patients with good and excellent outcomes 
at 50%. Minas and Peterson have large ACI series that have 
subpopulations that had bipolar TF salvage ACI restorations with 
good and excellent outcomes of 90% and 67% respectively. 
5IFSPMFBOEUFDIOJRVFTPGCJPMPHJD6,"XJMMDPOUJOVFUPCFSF¾OFE
Presently, with the excellent success of endoprosthetic UKA and 
TKA, patients in age groups classically treated with endoprosthetic 
will continue with that treatment. Biologic UKA and PFA will play a 
role primarily in the salvage treatment of young patients deemed too 
young for endoprosthetic arthroplasty. In the future as the success 
rates for these salvage procedures potentially improve, there may 
be potential of extending the age range. 
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